Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.

Gelijkaardige items

• Pharmacokinetic Evaluation of Oral Levofloxacin in Human Immunodeficiency Virus-Infected Subjects Receiving Concomitant Antiretroviral Therapy
  door: Villani, P., et al.
  Gepubliceerd in: (2001)
• Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection.
  door: Goodwin, S D, et al.
  Gepubliceerd in: (1994)
• Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects.
  door: Chien, S C, et al.
  Gepubliceerd in: (1997)
• Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.
  door: Chien, S C, et al.
  Gepubliceerd in: (1997)
• Pharmacokinetics and Safety of High-Dose and Extended-Interval Regimens of Levofloxacin in Human Immunodeficiency Virus-Infected Patients
  door: Piscitelli, Stephen C., et al.
  Gepubliceerd in: (1999)